Connect with us

News

ADB Promotes Innovation and Efficiency to Bolster Anticorruption Efforts

Published

on

The Asian Development Bank (ADB) is promoting innovation and efficiency to enhance its anticorruption efforts by streamlining case management and expediting the assessment of complaints and completion of investigations, according to the Office of Anticorruption and Integrity (OAI) 2019 Annual Report released today.

“We reassessed and rebalanced our resources to align with ADB’s long-term strategy, Strategy 2030,” said OAI Head John Versantvoort. “These measures have allowed us to provide better value to our stakeholders and achieve significant improvements in the number of completed investigations and complaints that we assessed and closed.”

In 2019, ADB concluded 110 investigations into integrity violations, a 93% increase from the previous year, and assessed and closed 219 complaints, an increase of 16%. ADB debarred 69 firms and 62 individuals for violating ADB’s Anticorruption Policy (1998, as amended since). It cross debarred 153 firms and 20 individuals sanctioned by other multilateral development banks. Imposition of other remedial actions against firms and individuals, such as reprimands and cautions, more than doubled from 2018.

Strengthening governance and institutional capacity to improve service delivery in ADB developing member countries is one of seven operational priorities under ADB’s Strategy 2030.

OAI conducted eight Proactive Integrity Reviews (PIRs) of ADB-financed projects in Afghanistan, Bhutan, Georgia, Indonesia, Kazakhstan, Myanmar, Nepal, and Palau. PIRs assess the application of sound financial management, procurement, and asset management practices by government agencies responsible for implementing ADB projects and recommend remedial measures for any shortcomings. In 2019, OAI conducted a PIR on an emergency assistance project for the first time.

“We are fully appreciative of the constructive review and recommendations that OAI has provided in the ongoing Nikachhu Hydropower project so that we can improve, benefit, and better manage our present and future projects,” said Managing Director of the Bhutan Druk Green Power Corporation Dasho Chhewang Rinzin, who is responsible for implementation of the project. “We will continue to work to ensure that the recommendations of the OAI report get implemented.”

ADB maintained quality screening methods to identify, assess, and mitigate integrity risks associated with its private sector counterparts and projects. It conducted integrity due diligence on 954 entities and issued 869 advisories on compliance. It provided capacity building support on anti-money laundering and combating the financing of terrorism in Mongolia, the Philippines, and Viet Nam. ADB also expanded its technical assistance to strengthen tax integrity standards to Armenia, Cambodia, Maldives, the Marshall Islands, the Federated States of Micronesia, Papua New Guinea, Samoa, and Thailand.

ADB launched its first gamified e-learning course and delivered 98 learning sessions, including trainings on anticorruption and respect at work to widen the reach of its knowledge-sharing and communication work. It also contributed to the G20’s Good Practices Guide on Promoting Integrity and Transparency in Infrastructure Development. It gathered representatives from 14 international financial institutions to strengthen integrity risk management in private sector transactions. Together with the Organisation for Economic Co-operation and Development and the Government of Viet Nam, ADB hosted a conference for the Anticorruption Initiative for Asia and the Pacific—the largest anticorruption network in the region.

Continue Reading
Comments

EU Politics

Coronavirus: EU Strategy for the development and availability of therapeutics

Published

on

The European Commission is today complementing the successful EU Vaccines Strategy with a strategy on COVID-19 therapeutics to support the development and availability of much-needed COVID-19 therapeutics, including for the treatment of ‘long COVID’. Today’s Strategy covers the full lifecycle of medicines: from research, development and manufacturing to procurement and deployment.

It is part of the strong European Health Union, in which all EU countries prepare and respond together to health crises and ensure the availability of affordable and innovative medical supplies – including the therapeutics needed to treat COVID-19.

The Strategy includes clear actions and targets, including authorising three new therapeutics to treat COVID-19 by October 2021 and possibly two more by end of the year. Concretely:

  • Research, development and innovation
    • Invest €90 million in population studies and clinical trials to establish links between risk factors and health outcomes to further inform public health policy and clinical management, including for long-COVID patients.
    • Set up a ‘therapeutics innovation booster’ by July 2021 to support the most promising therapeutics from preclinical research to market authorisation. It will build on current initiatives and investments in therapeutic development, working in a close cooperation with the European Health Emergency Preparedness and Response Authority (HERA) preparatory action on mapping therapeutics. It will therefore ensure the coordination of all research projects on COVID-19 therapeutics, stimulating innovation and boosting therapeutic development.
  • Access to and swift approval of clinical trials
    • Invest €5 million under the EU4Health programme to generate better, high-quality safety data in clinical trials, which will help produce robust results in a timely manner.
    • Provide EU countries with financial support of €2 million under the EU4Health 2021 work programme for expedited and coordinated assessments to facilitate approval of clinical trials.
    • Explore how to support developers of therapeutics to build capacity to produce high-grade material for clinical trials.
  • Scanning for candidate therapeutics
    • Invest €5 million to map therapeutics and diagnostics to analyse development phases, production capacities and supply chains, including possible bottlenecks.
    • Establish a broader portfolio of 10 potential COVID-19 therapeutics and identify five of the most promising ones by June 2021.
  • Supply chains and delivery of medicines
    • Fund a €40 million preparatory action to support flexible manufacturing and access for COVID-19 therapeutics under the EU Fab project, which in turn will become over time an important asset for the future the European Health Emergency Preparedness and Response Authority (HERA).
  • Regulatory flexibility
    • Authorise at least three new therapeutics by October and possibly two more by the end of the year and develop flexible regulatory approaches to speed up the assessment of promising and safe COVID-19 therapeutics.
    • Start seven rolling reviews of promising therapeutics by end-2021, subject to research and development outcomes.
  • Joint procurement and financing
    • Launch new contracts for the purchase of authorised therapeutics by the end of the year.
    • Secure faster access to medicines with shorter administrative deadlines.
  • International cooperation to make medicines available to all
    • Reinforce engagement for the therapeutics pillar of the Access to COVID-19 Tools Accelerator.
    • Boost ‘OPEN’ initiative for international collaboration.

Next Steps

The Commission will draw up a portfolio of 10 potential COVID-19 therapeutics and by June 2021, identify the five most promising ones. It will organise matchmaking events for industrial actors involved in therapeutics to ensure enough production capacity and swift manufacturing. New authorisations, rolling reviews and joint procurement contracts will be up and running before the end of the year.

The therapeutics innovation booster, matchmaking events and preparatory action to support flexible manufacturing and access for COVID-19 therapeutics under the EU Fab project, will feed into the HERA, for which a proposal is due later in the year. The pilot project on access to health data will feed into the European Health Data Space proposal expected later this year.

Members of the College said:

Vice-President for Promoting our European Way of Life, Margaritis Schinas, said: “The situation in many intensive care units across the continent remains critical. We need to focus both on vaccines and therapeutics, as two powerful and complementary ways to combat COVID-19. But currently we have only one authorised medicine to treat COVID-19. By acting on better availability of medicines today, we are making sure patients receive the treatments they need while also preparing our future biomedical preparedness. A coordinated strategy on quick access to therapeutics will boost our strategic autonomy and contribute to a strong Health Union.”

Commissioner for Health and Food Safety, Stella Kyriakides, said: “Vaccinations save lives, but they cannot yet eradicate COVID-19. We need a strong push on treatments to limit the need for hospitalisation, speed up recovery times, and reduce mortality. Patients in Europe and across the world should have access to world-class COVID-19 medicines. This is why we have set a very clear goal: by October, we will develop and authorise three new effective COVID-19 therapeutics that can have the potential to change the course of the disease. We will do so by investing in research and innovation, the identification of new promising medicines, ramping up production capacity and supporting equitable access. Our Therapeutics Strategy is a strong European Health Union in action.”

Commissioner for Innovation, Research, Culture, Education and Youth, Mariya Gabriel, said: “By increasing vaccine availability across Europe, more and more Europeans are now protected against COVID-19. In the meantime, the development of innovative medicines to treat coronavirus patients remains a priority when it comes to saving lives. Research and innovation is the first step to finding effective and safe therapeutics, which is why we are proposing to establish a new COVID-19 ‘therapeutics innovation booster’ and will invest € 90 million in population studies and clinical trials.

Background

The Strategy on COVID-19 therapeutics complements the EU strategy for COVID-19 vaccines from June 2020 and builds on ongoing work by the European Medicines Agency and the Commission to support research, development, manufacturing and deployment of therapeutics.

The Strategy forms part of a strong European Health Union, using a coordinated EU approach to better protect the health of our citizens, equip the EU and its Member States to better prevent and address future pandemics, and improve the resilience of Europe’s health systems.

Continue Reading

Development

Circular solution to Mosul’s conflict debris launched

Published

on

Photo credit: Gashtiyar Fathullah , IOM / 04 May 2021

Mosul – Iraq’s second largest city – suffered massive devastation during the conflict with the Islamic State in Iraq and the Levant (ISIL). An estimated 7-8 million tonnes of debris was created by the fighting, mainly in the Old City on the banks of the Tigris River. To deal with this huge debris challenge, the UN Environment Programme (UNEP) and the International Organization for Migration (IOM) are joining forces with Mosul Municipality – with the support of Japan – to establish the city’s first debris recycling center.

In the conflict’s immediate aftermath, clean-up campaigns cleared hundreds of thousands of tons of debris blocking streets to allow residents access to their homes and businesses, and enable rehabilitation of critical infrastructure such as hospitals, schools and water treatment plants.

The cleared debris, however, was often dumped in an uncontrolled manner in open spaces, gullies and strewn along roadsides for lack of designated disposal sites, creating problems in this city where land is a premium. Furthermore, much of the debris remains locked in damaged buildings which will require complex explosive hazard clearance and demolition and will take many years to release.

“By processing the rubble to produce quality materials that can be used in reconstruction efforts, creating much needed job opportunities for returnees and cleaning-up the urban environment, this initiative practically illustrates how humanitarian needs and sustainable development goals can be addressed in a joint manner,” said Dr. Jassim Humadi, Iraq’s Deputy Environment Minister.  “We are very grateful to the Government of Japan for their support in helping turn the debris problem in Mosul into a means of positive change.”  

The project builds upon lessons learned and best practices gathered under debris recycling pilots implemented jointly by IOM and UNEP in Mosul and Kirkuk. Where conventional practice had been to clear and dump the debris, this new initiative will concentrate on reusing the recycled aggregate for reconstruction.

“Material testing results confirming that the recycled aggregate complies with Iraq’s standards for road construction should also help pave the way for embedding circular economy principles in dealing with routine construction and demolition waste, thereby promoting a ‘building back better’ approach to crisis recovery,” said Gary Lewis, Director of UNEP’s Disasters and Conflicts Branch.

In the destroyed village of Buwaiter, where the pilot debris recycling project in Kirkuk was implemented, “unemployed youth with no work opportunities benefited immensely,” said Salal Othman, who guards the recycling site and used the crushed gravel to pave the area in front of his house, which is typically impassable during the rains.

“Young people in our village view debris recycling as a golden chance in terms of job creation, which additionally, by clearing the rubble, is allowing us to return and rebuild our homes,” added Mijbel Mar’i, a 24-year-old day labourer.

Remarking on the debris recycling in Buwaiter, Hassan Al-Jubouri, the head of Multaqa sub-district, described it as “an excellent step to dispose of huge volumes of debris while simultaneously employing people,” adding that “with this project, in addition to removing the debris we now have the possibility to reuse it. And given that many rural roads in our sub-district need surfacing, the crushed materials are ideal for this end.”

“Japan has provided over USD 500 million as humanitarian assistance to the people affected by the crisis since 2014. Additionally, Japan decided this year to provide a new assistance package to Iraq, amounting to USD 50 million, including this project by UNEP,” said Japan’s Ambassador to Iraq, His Excellency Mr. Kotaro Suzuki. “I commend UNEP’s initiative together with IOM on recycling debris which cleans up the urban environment and produces materials for road construction as well as creating job opportunities for unemployed youth.”

“In Japan, after the earthquakes, people mourned their loss and started to clean up the debris which was all that was left of their homes and memories of loved ones. Our fathers’ generation did the same in scorched cities after the war, to rebuild towns for their people, for their future children,” he added. “We want to assist people in Mosul and Kirkuk in their efforts to revive their towns, rebuild their lives once again.”

Continue Reading

Energy News

Hydrogen in North-Western Europe: A vision towards 2030

Published

on

North-West Europe has a well-developed hydrogen industry that could be at the edge of an unprecedented transformation should governments keep raising their ambitions for reducing greenhouse gas emissions, according to a new joint report by the International Energy Agency (IEA) and the Clingendael International Energy Programme (CIEP). 

The report, Hydrogen in North-Western Europe: A vision towards 2030, explores hydrogen developments, policies and potential for collaboration in the region. It was commissioned to inform discussions among governments from North-West Europe about the potential development of a regional hydrogen market. This intergovernmental dialogue was established at the Clean Energy Ministerial Hydrogen Initiative in 2020.

The report finds that the current policy landscape provides some momentum for the transformation of the hydrogen industry in North-West Europe towards 2030, but that it is insufficient to fully tap into the region’s potential to develop a large-scale low-carbon hydrogen value chain. More ambitious policies in line with the targets defined by the EU Green Deal or the UK Climate Change Act would drive a faster transformation.

If such a supportive policy framework were to be adopted, hydrogen demand in the region could grow by a third and low-carbon hydrogen could meet more than half of dedicated production, up from about 10% today, according to the report.

North-West European countries have already made significant progress developing their vision for the role hydrogen should play in their long-term energy strategies. These countries now face the challenge of moving beyond national discussions to establish a regional dialogue, an indispensable condition to develop the fully integrated hydrogen market the region needs. 

With the aim of informing this dialogue, the report identifies four priorities that should be addressed:

  • Build on the large unused potential to co-operate on hydrogen in the north-western European region.
  • Identify what is needed to develop an integrated regional market.
  • Develop supporting schemes with a holistic view of the hydrogen value chain.
  • Identify the best opportunities to simultaneously decarbonise current hydrogen production and deploy additional low-carbon supply.

Continue Reading

Publications

Latest

EU Politics25 mins ago

Coronavirus: EU Strategy for the development and availability of therapeutics

The European Commission is today complementing the successful EU Vaccines Strategy with a strategy on COVID-19 therapeutics to support the...

Development1 hour ago

Circular solution to Mosul’s conflict debris launched

Mosul – Iraq’s second largest city – suffered massive devastation during the conflict with the Islamic State in Iraq and...

Energy News2 hours ago

Hydrogen in North-Western Europe: A vision towards 2030

North-West Europe has a well-developed hydrogen industry that could be at the edge of an unprecedented transformation should governments keep...

Americas4 hours ago

Trump Lost, Biden Won. Is Joe Biden’s presidency a signal towards Obama’s America?

Greek statesmen, Pericles once said, “Just because you don’t take an interest in politics doesn’t mean the politics won’t take interest...

Green Planet6 hours ago

Climate Change Problem: an Emerging Threat to Global Security

Climate Change is one of the greatest challenges faced by humanity. The Greenhouse–gas emissions and over-exploitation of natural resources result...

Development7 hours ago

Viet Nam’s mango industry: towards compliance with export market requirements

A Swiss-funded project, implemented by the United Nations Industrial Development Organization (UNIDO), is helping mango value chain stakeholders in the...

Eastern Europe8 hours ago

Armenia After the Parliamentary Elections

On June 20, snap parliamentary elections will be held in Armenia. The move will ease tensions in the country but...

Trending